2017 annual financial data
Marker Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -4,610.1%.
Operating income was -11,480,000 USD and net income was -10,982,000 USD.
Operating cash flow was -8,439,427 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 183,064 USD
- Operating income
- -11,480,000 USD
- Net income
- -10,982,000 USD
- Operating cash flow
- -8,439,427 USD